Zynerba Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q2 2014 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Zynerba Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q2 2014 to Q1 2023.
  • Zynerba Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $51.6K, a 14.9% decline year-over-year.
  • Zynerba Pharmaceuticals, Inc. annual Depreciation for 2022 was $219K, a 11.3% decline from 2021.
  • Zynerba Pharmaceuticals, Inc. annual Depreciation for 2021 was $247K, a 19.4% increase from 2020.
  • Zynerba Pharmaceuticals, Inc. annual Depreciation for 2020 was $207K, a 54.6% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $51.6K -$9.06K -14.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $60.7K -$760 -1.24% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $227K $61.5K +$20.2K +49.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $207K $59.8K +$24.1K +67.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 $183K $57.8K +$21.8K +60.4% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $161K $48.2K +$15.3K +46.5% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $146K $41.2K +$12K +40.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $134K $35.7K +$9.3K +35.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $125K $36K +$11K +43.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $114K $32.9K +$11.3K +52.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $102K $29.3K +$2.69K +10.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $99.6K $26.4K +$534 +2.07% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-10
Q3 2018 $99K $25K +$270 +1.09% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $98.8K $21.6K -$1.59K -6.86% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $100K $26.6K +$6.15K +30.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $94.2K $25.8K +$3.84K +17.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-10
Q3 2017 $90.4K $24.8K -$1.07K -4.14% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $91.4K $23.2K +$9.28K +66.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $82.2K $20.4K +$6.86K +50.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $75.3K $22K +$8.75K +66% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-11
Q3 2016 $66.5K $25.8K +$17.6K +214% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $48.9K $13.9K +$10.8K +349% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $38.1K $13.6K +$12.1K +837% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $26K $13.3K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $8.23K +$1.38K +20.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $3.1K -$6.03K -66.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $1.45K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 $6.85K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $9.13K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.